Garin ‘ready’ to face raps over Dengvaxia: My conscience is clear | Inquirer

Garin ‘ready’ to face raps over Dengvaxia: My conscience is clear

By: - Reporter /
/ 07:17 PM February 12, 2018

Former Health Sec. Janette Loreto-Garin

Former Health Sec. Janette Loreto-Garin testifies at the Senate probe into Dengvaxia, the dengue vaccine procured and used for an immunization program during the Aquino administration.
INQUIRER PHOTO/LYN RILLON

Former Health Secretary Janette Garin on Monday said she is ready to face any case that will be filed against her in connection with the controversial anti-dengue vaccine Dengvaxia.

Garin is one of the respondents in the criminal complaint filed by the Volunteers Against Crime and Corruption (VACC) and Vanguard of the Philippine Constitution Inc. (VPCI) before the Department of Justice (DOJ).

Article continues after this advertisement

“I welcome the case. We are ready to face any of the charges because my conscience is clear. It’s better to transfer the venue of the debate in court and stop the hysteria being generated by misleading questions and conclusions,” she said in a text message to reporters.

FEATURED STORIES

She said because of the controversy, public health has been threatened.

“Our people do not deserve this. The proper forum can delineate facts, scrutinize experts and allow the truth to prevail,” she said. /je

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the and acknowledge that I have read the .

MOST READ
www
technology
globalnation
business
business
TAGS: case, complaint, Dengvaxia, DoH, DoJ, file, Garin, vaccine

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the and acknowledge that I have read the .

© Copyright 1997-2025 | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies.